Lopinavir-Ritonavir No Benefit in Patients Admitted With COVID-19
No reductions seen in 28-day mortality or duration of hospital stay in COVID-19 with lopinavir-ritonavir
Review: Estimated Prevalence of VTE 14.1 Percent in COVID-19
Venous thromboembolism found in 7.9 percent of non-ICU patients, 22.7 percent of ICU patients
Lake Jackson, Texas, Lifts Boil-Water Notice Triggered by Parasite
Notice lifted after disinfectant levels in drinking water were documented to be above the state requirements
White House Approves Tougher Rules for COVID-19 Vaccine Development
Guidelines recommend participants in late-stage trials be followed for a median of at least two months
Six States Set Records for COVID-19 Hospitalizations
Wyoming's 36.7 percent increase since last week in its rolling seven-week average was the largest of any state
Company Seeks FDA Emergency Approval for COVID-19 Antibody Therapy
Request based on partial clinical trial findings suggesting the drug reduces symptoms in mild or moderate COVID-19
Poll: Only Half of Americans Would Try to Get COVID-19 Vaccine
If enough people in the U.S. pass on vaccine, the nation may not be able to achieve herd immunity
Hydroxychloroquine Not Beneficial for SARS-CoV-2 Preexposure Prophylaxis
No clinical benefit seen versus placebo for hospital-based health care workers exposed to patients with COVID-19
CLABSI Rates Have Remained Stable in Neonatal, Pediatric ICUs
However, 2013 to 2018 saw decrease in population-based CAUTI rates, indwelling urinary catheter use
Cardiovascular Event Risk Up for Spouses of Patients in ICU
Increased odds found for visits for cardiovascular diseases one to four weeks after spouse's ICU admission
